Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 456-457, 2004; 10.1373/clinchem.2003.022210
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pereira, H. M.G.
Right arrow Articles by Aquino Neto, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pereira, H. M.G.
Right arrow Articles by Aquino Neto, F. R.
Related Collections
Right arrow Drug Monitoring and Toxicology
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2004;50:456-457.)
© 2004 American Association for Clinical Chemistry, Inc.

Letters to the Editor

Incidental Clostebol Contamination in Athletes after Sexual Intercourse

Henrique M.G. Pereira1, Marlice A.S. Marques1, Isadora B. Talhas1 and Francisco Radler Aquino Neto1,a

1 LABDOP/LADETEC, Instituto de Química, UFRJ, Rio de Janeiro, Brazil

aAuthor for correspondence. E-mail radler@iq.ufrj.br.

The first 20% of the full text of this article appears below.


To the Editor:

Clostebol is a synthetic androgenic steroid with anabolic effects that is frequently used in sports to increase physical performance. Because of medical and ethical reasons, the use of clostebol is prohibited by the International Olympic Committee (IOC) (1), and its misuse would fall under the strict liability rule of the IOC and the World Antidoping Agency. It is therefore the responsibility of athletes to submit evidence contrary to any ruling issued against them by the appropriate sports body. Despite the prohibition against the use of clostebol, abuse of this steroid is increasing, mainly in Brazilian athletes. In Brazil, clostebol acetate is present in medicines for dermatologic and gynecologic treatments, whereas in the US, the Food and Drug Administration does not approve of the use of medicines that contain anabolic agents.

Our laboratory, LABDOP, is accredited by the IOC . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.